Lokelma 5 g powder for oral suspension, Lokelma 10 g powder for oral suspension
KEEP-ON
Phase 3 small_molecule active
Quick answer
Lokelma 5 g powder for oral suspension, Lokelma 10 g powder for oral suspension for Hyperkalemia in patients with chronic kidney disease is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Hyperkalemia in patients with chronic kidney disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active